takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Deborah Dunsire M.D.
|Age||Total Calculated Compensation||This person is connected to 168 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Dr. Deborah Dunsire, MD has been the Chief Executive Officer and President of FORUM Pharmaceuticals Inc., since July 11, 2013. Dr. Dunsire served as the Chief Executive Officer and President at Millennium Pharmaceuticals, Inc., from July 2005 to May 2013. She has more than 25 years of scientific, clinical, operational and commercial experience, and proven leadership in the biological and pharmaceutical industry. Dr. Dunsire served as a Corporate Officer of Millennium ...
12-10, Nihonbashi 2-chomePhone: 81 3 3278 2111
Osaka, -- 103-8668
Fax: 81 3 3278 2000
Board Members Memberships*
Director At Large
Independent Director, Member of Science & Technology Committee and Member of Audit & Finance Committee
Chief Executive Officer, President and Director
Wits Medical School
University of the Witwatersrand
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.